- call +1-201-465-4211
- email sales@mrinsights.biz
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
Scope of the Report:
This report studies the Infectious Disease Diagnostics Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Infectious Disease Diagnostics Testing market by product type and applications/end industries.
Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.
The global Infectious Disease Diagnostics Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Infectious Disease Diagnostics Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Diagnostic
Alere
bioMérieux
Diasorin
Roche Diagnostic
Beckman Coulter
Becton, Dickinson and Company
Bio-Rad Laboratories
Cavidi
Cepheid
Corgenix
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Molecular diagnostic test
POC infectious disease diagnostics test
Market Segment by Applications, can be divided into
Respiratory
HIV
HAIs
Sexual health
Tropical diseases
Liver
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Infectious Disease Diagnostics Testing Market Overview
1.1 Product Overview and Scope of Infectious Disease Diagnostics Testing
1.2 Classification of Infectious Disease Diagnostics Testing by Types
1.2.1 Global Infectious Disease Diagnostics Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Types in 2017
1.2.3 Molecular diagnostic test
1.2.4 POC infectious disease diagnostics test
1.3 Global Infectious Disease Diagnostics Testing Market by Application
1.3.1 Global Infectious Disease Diagnostics Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Respiratory
1.3.3 HIV
1.3.4 HAIs
1.3.5 Sexual health
1.3.6 Tropical diseases
1.3.7 Liver
1.4 Global Infectious Disease Diagnostics Testing Market by Regions
1.4.1 Global Infectious Disease Diagnostics Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Infectious Disease Diagnostics Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Infectious Disease Diagnostics Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infectious Disease Diagnostics Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Infectious Disease Diagnostics Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infectious Disease Diagnostics Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Infectious Disease Diagnostics Testing (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Diagnostic
2.1.1 Business Overview
2.1.2 Infectious Disease Diagnostics Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Diagnostic Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Alere
2.2.1 Business Overview
2.2.2 Infectious Disease Diagnostics Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Alere Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 bioMérieux
2.3.1 Business Overview
2.3.2 Infectious Disease Diagnostics Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 bioMérieux Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Diasorin
2.4.1 Business Overview
2.4.2 Infectious Disease Diagnostics Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Diasorin Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche Diagnostic
2.5.1 Business Overview
2.5.2 Infectious Disease Diagnostics Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Diagnostic Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Beckman Coulter
2.6.1 Business Overview
2.6.2 Infectious Disease Diagnostics Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Beckman Coulter Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Becton, Dickinson and Company
2.7.1 Business Overview
2.7.2 Infectious Disease Diagnostics Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bio-Rad Laboratories
2.8.1 Business Overview
2.8.2 Infectious Disease Diagnostics Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cavidi
2.9.1 Business Overview
2.9.2 Infectious Disease Diagnostics Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cavidi Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cepheid
2.10.1 Business Overview
2.10.2 Infectious Disease Diagnostics Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cepheid Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 Corgenix
2.11.1 Business Overview
2.11.2 Infectious Disease Diagnostics Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Corgenix Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.12 Diaxonhit
2.12.1 Business Overview
2.12.2 Infectious Disease Diagnostics Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Diaxonhit Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.13 Eiken Chemical
2.13.1 Business Overview
2.13.2 Infectious Disease Diagnostics Testing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Eiken Chemical Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.14 EMD Millipore
2.14.1 Business Overview
2.14.2 Infectious Disease Diagnostics Testing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 EMD Millipore Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.15 Epitope Diagnostic
2.15.1 Business Overview
2.15.2 Infectious Disease Diagnostics Testing Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.16 EUROIMMUN
2.16.1 Business Overview
2.16.2 Infectious Disease Diagnostics Testing Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 EUROIMMUN Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.17 Gold Standard Diagnostics
2.17.1 Business Overview
2.17.2 Infectious Disease Diagnostics Testing Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.18 Hologic
2.18.1 Business Overview
2.18.2 Infectious Disease Diagnostics Testing Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Hologic Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.19 Immunetics
2.19.1 Business Overview
2.19.2 Infectious Disease Diagnostics Testing Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Immunetics Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
2.20 InBios International
2.20.1 Business Overview
2.20.2 Infectious Disease Diagnostics Testing Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 InBios International Infectious Disease Diagnostics Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Infectious Disease Diagnostics Testing Market Competition, by Players
3.1 Global Infectious Disease Diagnostics Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Infectious Disease Diagnostics Testing Players Market Share
3.2.2 Top 10 Infectious Disease Diagnostics Testing Players Market Share
3.3 Market Competition Trend
4 Global Infectious Disease Diagnostics Testing Market Size by Regions
4.1 Global Infectious Disease Diagnostics Testing Revenue and Market Share by Regions
4.2 North America Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
4.5 South America Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
5 North America Infectious Disease Diagnostics Testing Revenue by Countries
5.1 North America Infectious Disease Diagnostics Testing Revenue by Countries (2013-2018)
5.2 USA Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
6 Europe Infectious Disease Diagnostics Testing Revenue by Countries
6.1 Europe Infectious Disease Diagnostics Testing Revenue by Countries (2013-2018)
6.2 Germany Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
6.3 UK Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
6.4 France Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Infectious Disease Diagnostics Testing Revenue by Countries
7.1 Asia-Pacific Infectious Disease Diagnostics Testing Revenue by Countries (2013-2018)
7.2 China Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
7.5 India Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
8 South America Infectious Disease Diagnostics Testing Revenue by Countries
8.1 South America Infectious Disease Diagnostics Testing Revenue by Countries (2013-2018)
8.2 Brazil Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Infectious Disease Diagnostics Testing by Countries
9.1 Middle East and Africa Infectious Disease Diagnostics Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Infectious Disease Diagnostics Testing Revenue and Growth Rate (2013-2018)
10 Global Infectious Disease Diagnostics Testing Market Segment by Type
10.1 Global Infectious Disease Diagnostics Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Infectious Disease Diagnostics Testing Market Forecast by Type (2018-2023)
10.3 Molecular diagnostic test Revenue Growth Rate (2013-2023)
10.4 POC infectious disease diagnostics test Revenue Growth Rate (2013-2023)
11 Global Infectious Disease Diagnostics Testing Market Segment by Application
11.1 Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2013-2018)
11.2 Infectious Disease Diagnostics Testing Market Forecast by Application (2018-2023)
11.3 Respiratory Revenue Growth (2013-2018)
11.4 HIV Revenue Growth (2013-2018)
11.5 HAIs Revenue Growth (2013-2018)
11.6 Sexual health Revenue Growth (2013-2018)
11.7 Tropical diseases Revenue Growth (2013-2018)
11.8 Liver Revenue Growth (2013-2018)
12 Global Infectious Disease Diagnostics Testing Market Size Forecast (2018-2023)
12.1 Global Infectious Disease Diagnostics Testing Market Size Forecast (2018-2023)
12.2 Global Infectious Disease Diagnostics Testing Market Forecast by Regions (2018-2023)
12.3 North America Infectious Disease Diagnostics Testing Revenue Market Forecast (2018-2023)
12.4 Europe Infectious Disease Diagnostics Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Infectious Disease Diagnostics Testing Revenue Market Forecast (2018-2023)
12.6 South America Infectious Disease Diagnostics Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Infectious Disease Diagnostics Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Infectious Disease Diagnostics Testing Picture
Table Product Specifications of Infectious Disease Diagnostics Testing
Table Global Infectious Disease Diagnostics Tes
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
